67 related articles for article (PubMed ID: 29480348)
1. Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situ.
McElree IM; Mott SL; Hougen HY; Packiam VT; O'Donnell MA; Steinberg RL
Urol Oncol; 2024 Jul; 42(7):221.e9-221.e16. PubMed ID: 38609747
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Intraluminal Therapies in Upper Tract Urothelial Carcinoma: A Narrative Review.
Tyrrell J; Chui W; Kealey J; Sengupta S
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792009
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic Cryoablation Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Chen Y; Xu C; Mou Z; Hu Y; Yang C; Hu J; Chen X; Luo J; Zou L; Jiang H
Eur Urol Oncol; 2024 Apr; ():. PubMed ID: 38693018
[TBL] [Abstract][Full Text] [Related]
4. Vesicoureteral reflux postoperative radical nephroureterectomy for upper urinary tract urothelial carcinoma: A case report.
Mahyoub MA; Yousef BM; Ghaleb RAM; Obad S; Mothanna A; Al-Yousofy F; Elhoumed M; Abbas M; Alnaggar M; Ren M; He S
Heliyon; 2024 May; 10(9):e30294. PubMed ID: 38707276
[TBL] [Abstract][Full Text] [Related]
5. Surgical and oncological outcomes of robot-assisted versus laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: A single-center comparative analysis.
Vasudeo V; Singh A; Khanna A; Rawal SK; Pratihar SK; Saurabh N; Kumar B; Ali M; Sharma P; Akotkar S; Sharma G; Kesarwani B
Indian J Urol; 2023; 39(4):285-291. PubMed ID: 38077196
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytic syndrome in A patient of upper urinary tract urothelial cancer after Bacillus Calmette-Guérin instillation: A case report.
Li TL; Huang CP; Lin CY; Ho MW; Cho CH; Chen YH; Chen WC
Urol Case Rep; 2024 May; 54():102730. PubMed ID: 38601084
[TBL] [Abstract][Full Text] [Related]
7. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.
Inoue T; Miyazaki J; Ichioka D; Narita S; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Matsui Y; Fujie K; Habuchi T; Nishiyama H
BMC Cancer; 2018 Mar; 18(1):290. PubMed ID: 29540229
[TBL] [Abstract][Full Text] [Related]
8. Correction: Systematic oxidative stress indices predicts prognosis in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy.
Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
Eur J Med Res; 2023 Dec; 28(1):615. PubMed ID: 38129930
[No Abstract] [Full Text] [Related]
9. Primary Carcinoma In Situ of the Ureter Without Concurrent Renal Pelvis or Bladder Carcinoma: A Case Report and Literature Review.
Farah M; Al-Dhahir W; Song M; Mahmalji W; Mohamed A
Cureus; 2023 Aug; 15(8):e43453. PubMed ID: 37593067
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
Cinque A; Capasso A; Vago R; Floris M; Lee MW; Minnei R; Trevisani F
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269744
[TBL] [Abstract][Full Text] [Related]
11. Role of Ureteroscopy in Treatment of Upper Tract Urothelial Carcinoma.
Ng Chieng Hin J; Hettiarachchilage D; Gravestock P; Rai B; Somani BK; Veeratterapillay R
Curr Urol Rep; 2021 Oct; 22(10):49. PubMed ID: 34622345
[TBL] [Abstract][Full Text] [Related]
12. [Instillation therapies for urothelial carcinoma of the upper urinary tract].
Bosshard P; Thalmann GN; Roth B
Urologe A; 2019 Jan; 58(1):25-29. PubMed ID: 30649582
[TBL] [Abstract][Full Text] [Related]
13. Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.
Okita K; Hatakeyama S; Fujita N; Konishi S; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Ito H; Yoshikawa K; Koie T; Ohyama C
Med Oncol; 2018 Nov; 36(1):7. PubMed ID: 30478763
[TBL] [Abstract][Full Text] [Related]
14. Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.
Konishi S; Hatakeyama S; Tanaka T; Ikehata Y; Tanaka T; Fujita N; Ishibashi Y; Yamamoto H; Yoneyama T; Hashimoto Y; Yoshikawa K; Kawaguchi T; Masumori N; Kitamura H; Ohyama C
Med Oncol; 2018 Nov; 36(1):6. PubMed ID: 30474747
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.
Iwamura H; Hatakeyama S; Sato M; Ohyama C
Med Oncol; 2018 May; 35(6):94. PubMed ID: 29744601
[TBL] [Abstract][Full Text] [Related]
16. Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.
Horiguchi H; Yoneyama T; Hatakeyama S; Tokui N; Sato T; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Narita S; Kawaguchi T; Ohyama C
Med Oncol; 2018 Feb; 35(4):41. PubMed ID: 29480348
[TBL] [Abstract][Full Text] [Related]
17. Management of primary upper urinary tract carcinoma in situ diagnosed by ureteroscopic biopsy: Is bacillus Calmette-Guerin an alternative to nephroureterectomy?
Territo A; Fontanet S; Meneghetti I; Gallioli A; Sanguedolce F; Rodriguez-Faba Ó; Gaya JM; Palou J; Huguet J; Breda A
Actas Urol Esp (Engl Ed); 2023 May; 47(4):221-228. PubMed ID: 36379260
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
[TBL] [Abstract][Full Text] [Related]
19. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
Thalmann GN; Markwalder R; Walter B; Studer UE
J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
